NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame.
A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss.
Yet Jobling’s experience also has altered his perspective on dieting. He now sees obesity as a disease that requires medical intervention, not just behavioral changes. In fact, he thinks he will need to stay on a drug like Wegovy for the rest of his life even though it has taken some of the joy out of eating.
Murder trial opens in death of Detroit
Watch Ryan Garcia get into an X
Iris Law puts on a very leggy display as she steps out wearing tiny grey shorts in West Hollywood
Rock trailblazer Heart reunites for a world tour and a new song
Minnesota ethics panel to consider how to deal with senator charged with burglary
Taylor Swift channels her bridal Grammy look in Fortnight video teaser
The Walking Dead star Tom Payne 'unexpectedly' welcomes TWINS with model wife Jennifer Akerman
FedEx pledges $25 million over 5 years in NIL program for University of Memphis athletes
US seeks information from Tesla on how it developed and verified whether Autopilot recall worked
Taylor Swift channels her bridal Grammy look in Fortnight video teaser
Luis Miranda Jr. reflects on giving, the arts and his son Lin
Ukraine, Israel aid bill on track as House pushes toward votes